These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4973521)

  • 1. [Erythroblastemia in a newborn infant].
    Brunecký Z; Hosková A
    Cesk Pediatr; 1968 Oct; 23(10):951-3. PubMed ID: 4973521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemolytic disease of the newborn due to incompatibility of the Rhc subgroup].
    Marks-Zakrzewska A; Helińska C
    Pediatr Pol; 1969 Oct; 44(11):1429-31. PubMed ID: 4982570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Materno-fetal Rh-factor isoimmunization without hemolytic disease].
    Di Palma L; Carcano G; Manzi F
    Pediatria (Napoli); 1975 Jun; 83(2):317-25. PubMed ID: 809742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemolytic disease of the newborn caused by Rh isoimmunization in first-born children].
    Lange MM; Corsino G; Perfetto V
    Minerva Pediatr; 1968 Mar; 20(11):623-4. PubMed ID: 4983211
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incidence of erythroblastosis in the umbilical cord blood of newborn infants with materno-fetal Rh factor incompatibility without signs of isoimmunization].
    Moscatelli P; Pantarotto F; Melevendi C
    Minerva Pediatr; 1967 Oct; 19(43):1901-2. PubMed ID: 4974603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic and pathogenic problems posed by hemolytic diseases caused by Rhesus incompatibility of the firstborn infant].
    Gabriel H
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):231-2. PubMed ID: 4220063
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the sulfhydryl group and protein fraction composition of the blood serum in pregnancy, labor and the newborn with RH-factor incompatibility].
    Gen' SA; Novikova NV
    Akush Ginekol (Mosk); 1969 Feb; 45(2):49-52. PubMed ID: 5002950
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of RH-HR blood group incompatibility].
    Seyfriedowa H
    Acta Haematol Pol; 1979 Oct; 10(4):221-6. PubMed ID: 120092
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
    Kanra T; Tunçer M; Pirnar A
    Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical and clinical problems in hemolytic disease of the newborn].
    Kaloud H
    Wien Med Wochenschr; 1966 Nov; 116(46):975-80. PubMed ID: 4965842
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intrauterine blood transfusion and postnatal hydrops therapy in Rh system hemolytic disease of the newborn].
    Protzen H; Kleiminger D; Gidion R; Fischer K
    Dtsch Med Wochenschr; 1967 Apr; 92(17):781-5. PubMed ID: 4960802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of leukocytic isosensitization in pregnancy on the condition of the newborn infant].
    Kuznechikova VV; Vasil'eva ZF; Poliakova GP
    Vopr Okhr Materin Det; 1971 Jan; 16(1):40-5. PubMed ID: 4995798
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmapheresis in Rh immunized pregnant women.
    Simonovits I; Vedrödi K; Jókuti I; Forgács J; Gy S
    Acta Haematol Pol; 1981; 12(2):65-7. PubMed ID: 6795880
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON A CASE OF ANTI-RH IMMUNIZATION CAUSED BY INCOMPATIBLE TRANSFUSION. CLINICAL AND MEDICO-LEGAL ASPECTS].
    MORINI A; RUSSO R
    Minerva Ginecol; 1963 Aug; 15():777-9. PubMed ID: 14083387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.